当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Aylin Bican, Ibrahim Bora, Ilker M Kafa and Mustafa A Kurt
Abstract
Epidemiological and recent prospective analyses of long Febrile Seizures (FS) support the idea that such seizures
can provoke Temporal Lobe Epilepsy (TLE) in some children. Because of the high prevalence of these seizures, if
epilepsy was to arise as their direct consequence, this would constitute a significant clinical problem. Animal studies
have revealed that exposure of hippocampal neurons to FS early in life, particularly prolonged or frequently repetitive
FS, or together with brain malformation, may lead to sustained dysfunction of these cells including long-term memory
impairment or epileptogenesis, in spite of the absence of neuronal damage. We established a hyperthermia model
of febrile convulsions in young adult rats, and studied the effects of propofol treatment general anesthetic acting via
GABA-A receptor on epileptiform activity and the morphological features of medial temporal lobe.
We found statistically significant neuronal losses in the CA1, CA3 and dentate gyrus regions of hyperthermiaapplied
rats as compared to the control rats. We also observed that propofol administration suppressed epileptic
discharges in EEG and prevented clinical seizures behaviors. It took a median of 11 (range, 6-40) minutes for propofol
to stop seizures. We conclude that prevention of epilepsy-related damage can be achieved via epileptogenesis-based
clinical approaches, and that propofol is an effective agent in the hyperthermia-induced status epilepticus model.